Yolk sac cell atlas reveals multiorgan functions during human early development.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
18 08 2023
Historique:
medline: 21 8 2023
pubmed: 17 8 2023
entrez: 17 8 2023
Statut: ppublish

Résumé

The extraembryonic yolk sac (YS) ensures delivery of nutritional support and oxygen to the developing embryo but remains ill-defined in humans. We therefore assembled a comprehensive multiomic reference of the human YS from 3 to 8 postconception weeks by integrating single-cell protein and gene expression data. Beyond its recognized role as a site of hematopoiesis, we highlight roles in metabolism, coagulation, vascular development, and hematopoietic regulation. We reconstructed the emergence and decline of YS hematopoietic stem and progenitor cells from hemogenic endothelium and revealed a YS-specific accelerated route to macrophage production that seeds developing organs. The multiorgan functions of the YS are superseded as intraembryonic organs develop, effecting a multifaceted relay of vital functions as pregnancy proceeds.

Identifiants

pubmed: 37590359
doi: 10.1126/science.add7564
pmc: PMC7614978
mid: EMS185071
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadd7564

Subventions

Organisme : Wellcome Trust
ID : 215116
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206328
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206194
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R006237/1
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R01 HL151777
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107931
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 211276
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107630
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 220540
Pays : United Kingdom

Références

Nat Biotechnol. 2022 Feb;40(2):163-166
pubmed: 35132262
Cell Prolif. 2021 Apr;54(4):e13012
pubmed: 33656760
Nat Methods. 2019 Jan;16(1):43-49
pubmed: 30573817
Elife. 2021 May 04;10:
pubmed: 33944782
Hum Mol Genet. 2020 Nov 25;29(19):3224-3248
pubmed: 32959884
Sci Rep. 2019 Mar 26;9(1):5233
pubmed: 30914743
Science. 2022 May 13;376(6594):eabl5197
pubmed: 35549406
Cell Stem Cell. 2021 Mar 4;28(3):535-549.e8
pubmed: 33340451
Nature. 2019 Oct;574(7778):365-371
pubmed: 31597962
Immunity. 2016 Mar 15;44(3):439-449
pubmed: 26982352
Cell Stem Cell. 2008 Mar 6;2(3):252-63
pubmed: 18371450
Nat Cell Biol. 2016 Jan;18(1):21-32
pubmed: 26619147
Nat Commun. 2020 Jul 28;11(1):3760
pubmed: 32724077
Blood. 2009 Apr 9;113(15):3461-71
pubmed: 19211936
Sci Immunol. 2022 Jan 07;7(67):eabf7777
pubmed: 34995099
J Exp Med. 2011 Nov 21;208(12):2417-27
pubmed: 22042975
Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7799-804
pubmed: 20385801
Front Cell Dev Biol. 2019 Jun 12;7:105
pubmed: 31245372
Nat Cell Biol. 2019 Nov;21(11):1334-1345
pubmed: 31685991
Stem Cell Res Ther. 2019 Nov 19;10(1):327
pubmed: 31744536
Stem Cells. 2016 Feb;34(2):431-44
pubmed: 26418893
Cell. 2015 Mar 12;160(6):1061-71
pubmed: 25728668
Development. 1998 Nov;125(22):4575-83
pubmed: 9778515
Nat Biotechnol. 2022 Feb;40(2):245-253
pubmed: 34594043
Nat Commun. 2022 Apr 19;13(1):2099
pubmed: 35440536
Science. 2017 Apr 21;356(6335):
pubmed: 28428369
Genome Biol. 2018 Feb 6;19(1):15
pubmed: 29409532
Nat Methods. 2019 Dec;16(12):1289-1296
pubmed: 31740819
Cell. 1995 Oct 6;83(1):59-67
pubmed: 7553874
Nat Neurosci. 2021 Apr;24(4):584-594
pubmed: 33723434
Nat Methods. 2019 Sep;16(9):870-874
pubmed: 31384047
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Int J Dev Biol. 2010;54(6-7):1011-8
pubmed: 20711979
Cell Discov. 2020 Dec 1;6(1):89
pubmed: 33298886
Nat Cell Biol. 2023 Jul;25(7):1061-1072
pubmed: 37322291
Nature. 2021 Dec;600(7888):285-289
pubmed: 34789876
Science. 2022 May 13;376(6594):eabl4896
pubmed: 35549404
Front Cell Dev Biol. 2021 Jul 22;9:705410
pubmed: 34368155
Science. 2010 Nov 5;330(6005):841-5
pubmed: 20966214
Nat Methods. 2018 Dec;15(12):1053-1058
pubmed: 30504886
Nat Commun. 2022 May 24;13(1):2885
pubmed: 35610203
Science. 2023 Aug 18;381(6659):eadd7564
pubmed: 37590359
Science. 2022 Jun 3;376(6597):eabo0510
pubmed: 35549310
Nature. 2022 Jul;607(7919):540-547
pubmed: 35794482
Mol Biol Cell. 2007 Dec;18(12):5014-23
pubmed: 17928406
Nature. 2022 Mar;603(7903):885-892
pubmed: 35165441
Cell Res. 2019 Nov;29(11):881-894
pubmed: 31501518
Nat Commun. 2021 Sep 6;12(1):5289
pubmed: 34489419
Cell Stem Cell. 2020 Nov 5;27(5):822-839.e8
pubmed: 32946788
Elife. 2022 Feb 15;11:
pubmed: 35166672
Cell. 2017 Mar 23;169(1):161-173.e12
pubmed: 28340341
Front Cell Dev Biol. 2018 Jul 20;6:80
pubmed: 30079337
Nature. 1985 Jan 17-23;313(5999):235-8
pubmed: 2578614
Proc Natl Acad Sci U S A. 2017 Jun 13;114(24):E4753-E4761
pubmed: 28559354
Cell Syst. 2019 Apr 24;8(4):281-291.e9
pubmed: 30954476
Thromb Res. 2010 Apr;125 Suppl 2:S36-8
pubmed: 20434002
Nature. 2022 Apr;604(7906):534-540
pubmed: 35418685
Curr Protoc Mol Biol. 2010 Oct;Chapter 14:Unit14.20
pubmed: 20890901
Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3422-7
pubmed: 12626754
Nature. 2020 Jun;582(7813):571-576
pubmed: 32499656
Science. 2019 Sep 27;365(6460):1461-1466
pubmed: 31604275
Int J Mol Med. 2020 Oct;46(4):1321-1334
pubmed: 32945351
Cell Stem Cell. 2007 Dec 13;1(6):685-97
pubmed: 18371409
Front Physiol. 2014 Jan 28;5:3
pubmed: 24478716
Development. 1999 Feb;126(4):793-803
pubmed: 9895326
Cell Stem Cell. 2012 Nov 2;11(5):663-75
pubmed: 23122290
Angiogenesis. 2021 May;24(2):199-211
pubmed: 33783643
Proc Natl Acad Sci U S A. 1984 Apr;81(8):2416-20
pubmed: 6201856
Cell. 2019 Jul 25;178(3):686-698.e14
pubmed: 31257031
Immunology. 2013 Jul;139(3):318-27
pubmed: 23320737
Nature. 1993 Jul 1;364(6432):64-7
pubmed: 8316298
Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7603-7
pubmed: 9636196
Nature. 2021 Oct;598(7880):327-331
pubmed: 34588693
Nat Protoc. 2020 Apr;15(4):1484-1506
pubmed: 32103204

Auteurs

Issac Goh (I)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Rachel A Botting (RA)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Antony Rose (A)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Simone Webb (S)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Justin Engelbert (J)

Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Yorick Gitton (Y)

Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.

Emily Stephenson (E)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Mariana Quiroga Londoño (M)

Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, Cambridge CB2 0AW, UK.

Michael Mather (M)

Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Nicole Mende (N)

Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, Cambridge CB2 0AW, UK.

Ivan Imaz-Rosshandler (I)

Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, Cambridge CB2 0AW, UK.
MRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge CD2 0QH, UK.

Lu Yang (L)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.

Dave Horsfall (D)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Daniela Basurto-Lozada (D)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Nana-Jane Chipampe (NJ)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.

Victoria Rook (V)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.

Jimmy Tsz Hang Lee (JTH)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.

Mai-Linh Ton (ML)

Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, Cambridge CB2 0AW, UK.

Daniel Keitley (D)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK.

Pavel Mazin (P)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.

M S Vijayabaskar (MS)

Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, Cambridge CB2 0AW, UK.

Rebecca Hannah (R)

Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, Cambridge CB2 0AW, UK.

Laure Gambardella (L)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.

Kile Green (K)

Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Stephane Ballereau (S)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.

Megumi Inoue (M)

Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.

Elizabeth Tuck (E)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.

Valentina Lorenzi (V)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.

Kwasi Kwakwa (K)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.

Clara Alsinet (C)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Centre Nacional d'Analisi Genomica-Centre de Regulacio Genomica (CNAG-CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.

Bayanne Olabi (B)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Mohi Miah (M)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Chloe Admane (C)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Dorin-Mirel Popescu (DM)

Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Meghan Acres (M)

Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

David Dixon (D)

Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Thomas Ness (T)

NovoPath, Department of Pathology, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne NE1 4LP, UK.

Rowen Coulthard (R)

NovoPath, Department of Pathology, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne NE1 4LP, UK.

Steven Lisgo (S)

Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Deborah J Henderson (DJ)

Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Emma Dann (E)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.

Chenqu Suo (C)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.

Sarah J Kinston (SJ)

Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, Cambridge CB2 0AW, UK.

Jong-Eun Park (JE)

Korea Advanced Institute of Science and Technology, Daejeon, South Korea.

Krzysztof Polanski (K)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.

John Marioni (J)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
EMBL-EBI, Wellcome Genome Campus, Cambridge CB10 1SD, UK.
CRUK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.

Stijn van Dongen (S)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.

Kerstin B Meyer (KB)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.

Marella de Bruijn (M)

MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DS, UK.

James Palis (J)

Department of Pediatrics, University of Rochester Medical Center, Rochester, NY 14642, USA.

Sam Behjati (S)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.

Elisa Laurenti (E)

Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, Cambridge CB2 0AW, UK.

Nicola K Wilson (NK)

Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, Cambridge CB2 0AW, UK.

Roser Vento-Tormo (R)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.

Alain Chédotal (A)

Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.

Omer Bayraktar (O)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.

Irene Roberts (I)

Department of Paediatrics, University of Oxford, Oxford OX3 9DS, UK.

Laura Jardine (L)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Berthold Göttgens (B)

Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, Cambridge CB2 0AW, UK.

Sarah A Teichmann (SA)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Theory of Condensed Matter Group, Department of Physics, Cavendish Laboratory, University of Cambridge, Cambridge CB3 0HE, UK.

Muzlifah Haniffa (M)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Biosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne NE1 4LP, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH